DDS: financial statements from SEC — TradeAlmanac

DDS

Dillard's, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Apr 30, 2026	Oct 31, 2025	Jul 31, 2025	Apr 30, 2025	Oct 31, 2024	Jul 31, 2024
Revenue	1.59bn	1.49bn	1.54bn	1.55bn	1.45bn	1.51bn
Cost of revenue	870m	832m	959m	858m	819m	930m
Selling, general and administrative	444m	440m	434m	422m	419m	434m
Pre-tax income	327m	169m	95m	214m	163m	97m
Income tax	77m	39m	22m	50m	38m	23m
Net income	251m	130m	73m	164m	125m	74m
Earnings per share	16.04	8.31	4.66	10.39	7.73	4.59
Earnings per share, diluted	16.04	8.31	4.66	10.39	7.73	4.59

Balance sheet

Metric	Apr 30, 2026	Jan 31, 2026	Oct 31, 2025	Jul 31, 2025	Apr 30, 2025	Jan 31, 2025	Oct 31, 2024	Jul 31, 2024
Cash and equivalents	1.16bn	861m	1.15bn	1.01bn	901m	718m	980m	947m
Receivables	47m	40m	45m

Cash flow

Metric	Apr 30, 2026	Oct 31, 2025	Jul 31, 2025	Apr 30, 2025	Oct 31, 2024	Jul 31, 2024
Operating cash flow	364m	—	—	233m	—	—
Depreciation and amortisation	43m	44m	45m	44m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)